4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-23-069566
Chairman & CEO bought 350 shares at an average $17.45 ($6,108)
From the SEC's structured data for this filing
Trades in this filing
BENTSUR RON · Chairman & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-07 | Purchase : show line 1 in the form | +230 | $17.41 | $4,004 | 3,229,409 | D |
| 2023-06-08 | Purchase : show line 2 in the form | +120 | $17.53 | $2,104 | 3,229,529 | D |
| Open-market purchases · 350 sh · avg $17.45 · $6,108 | ||||||
Loading xslF345X04/tm2318125-1_4seq1.xml…